We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

2 hedge funds and large institutions have $26K invested in BioDelivery Sciences International, Inc. in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 152 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,033% more call options, than puts

Call options by funds: $34K | Put options by funds: $3K

99% less funds holding

Funds holding: 1562 (-154)

100% less capital invested

Capital invested by funds: $181M → $26K (-$181M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 152

Holders
2
Holders Change
-154
Holders Change %
-98.72%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
152
Calls
$34K
Puts
$3K
Net Calls
+$31K
Net Calls Change
-$4.72M
Name Holding Trade Value Shares
Change
Change in
Stake
MPWT
151
MassMutual Private Wealth & Trust
Connecticut
-$1K -195 Closed

BDSI Hedge Fund Activity: Q1 2022 in Review

2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2022, worth a combined $26K — down 100% from $181M a quarter earlier.

Sellers outnumbered buyers: 152 funds closed out of BDSI and 0 opened new positions — a net loss of 152 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $22.6M sold.

  • 2 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2022, down from 156 in Q4 2021.
  • Funds reported $26K of BioDelivery Sciences International, Inc. stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2022 and 152 closed out, a net change of -152 holders.
  • The largest BioDelivery Sciences International, Inc. seller in Q1 2022 was BlackRock, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2022.